PARASITICIDAL COMPOSITION AND METHODS FOR ITS MAKING AND USE

Abstract: A liquid phase composition of a pyrethroid in concentrations greater than 50 % w/w that may be used as a basis for other pyrethroid containing formulations in physical phases other than the liquid phase is described. A method of treatment utilizing the composition on domestic mammals is also described.

Description: PARASITICIDAL COMPOSITION AND METHODS FOR ITS MAKING AND USE This invention relates in general to a composition for controlling ectoparasites. More particularly this invention relates to such a composition employing a pyrethroid in concentrations greater than 50% w/w. 5 Ectoparasites such as ticks and fleas are often found on domesticated animals, such as dogs. Ectoparasites will feed off their animal host and are a constant source of irrita¬ tion to the animal. It is therefore desirable to control 10 such infestations. By control, it is meant that, desirably, all parasites on the host are killed. Control of tick infestation on all mammals, especially household pets, has recently assumed greater importance than at any other recent time because of the discovery that certain tick species may 15 carry the micro-organism responsible for the transmission of Lyme disease to humans. While there are known compositions and methods for control¬ ling ectoparasites, many of them are systemic products. 20 That is, they are products containing active parasiticides that enter the bloodstream of the animal in order to create the insecticidal effect. Systemic insecticides are general¬ ly less desirable if suitable alternatives exist. They have shown some efficacy against fleas, but have generally not 25 been useful in controlling ticks. Because systemic products, even if topically applied, must enter into the host bloodstream, they are more likely to be toxic to the host. In addition, systemic products that are not applied topically can be difficult to administer. They may require injection equipment or involve the difficult task of getting an animal to swallow oral formulations. Liquid compositions containing up to 50% w/w of a pyrethroid are known as are methods for applying said formulations topically. See for example, U.K. Pat. 2,088,212 to Kieran & Townsend, hereafter referred to as -212. However, known compositions do not encompass the formulation of liquid compositions containing greater than 50% by weight/weight of pyrethroid, like those of the instant invention. It is surprising that such concentrated formulations do not cause irritation and toxicity. It would be anticipated that highly concentrated solutions of a pyrethroid, when applied to the skin, would be absorbed into the host and result in systemic toxicity. The present invention encompasses a topical formulation of greater than 50% w/w of a pyrethroid that is non-irritating and non-toxic to the host animal as well as a method of controlling ectoparasites utilizing such formulation. It is believed that one reason why the prior art does not teach the use of such highly concentrated pyrethroid formu¬ lations is because of the solvent systems heretofore em- ployed. For example, U. K. Patent No. 2,088,212 teaches the dissolution of solid pyrethroids into liquid formulations by using undesirable, irritating, organic solvents such as xylene, toluene, and cyclohexanone. It teaches the use of one of these solvents in conjunction with alkyl glycol ethers. It also teaches the use of combinations of the three organic solvents in conjunction with a glycol. The referenced ϋ. K. patent does not teach the use of glycols without adding undesirable, irritating, organic solvents. Those skilled in the art would not expect that the weak solvent power of the glycols could be compatible with com¬ mercial production methods. When the active ingredients according to the present invention are formulated in an alkyl glycol ether solvent, the resulting liquid formulation can then be used as an ingredient in formulating other topical compositions. Concentrations of more than 50% make topical application of the composition more convenient than ever before. The higher the concentration, the smaller the dose for effective ectoparasite control. Such small doses can be applied without the treated animal being made aware thus easing administration. Formulations containing more than 50% w/w of a pyrethroid thus obtain many advantages not taught by the prior art of using formulations with maximum concentra¬ tions of up to 50%. Topical compositions can be formulated to take a variety of physical states. They can be a mixture of liquids or a solid active agent can be dissolved in solution. Alternatively, the active agent may be carried in a suspension or emulsion. The suspensions can be water or oil based sols, gels, or ointments. Emulsion carriers contain both aqueous and oily components and can take the form of creams, lotions, or ointments. In addition, topical administration is further made conven¬ ient if the active agent insecticide is contained in an optimal composition. An optimal composition has the follow¬ ing characteristics. The active agent comprises more than 50% of the active agent so that the smallest effective dose may be achieved. During application and while on the host, the carrier components of the formulation facilitate deliv- ery, adsorption on the hair and distribution of the active agent to the parasite. The carrier may inhibit absorption of the active agent into the host and thus avoid systemic toxicity. In the optimal composition, the carrier may also comprise ingredients that soothe or prevent irritation as well as merely employing solvents that are non-irritating. The choice of carrier can also be varied to optimize fre¬ quency of dosing according to particular environmental conditions. For example, oily carriers resist washing. Formulations comprised of oily carriers reduce dosing fre¬ quency for hosts exposed to rain and water. Formulations comprised of aqueous carriers are more suited to dry envi¬ rons. If the host is in dry environs the aqueous formula- tion is less likely to be washed off and the required fre¬ quency of dosing remains low. Formulations with pyrethroid concentrations in excess of 50% w/w can be packaged in a single dose package. For example, a single 1 cc dose of a liquid formulation comprised of permethrin and 35% 2-(2-methoxyethoxy)ethanol can be pack¬ aged in a collapsible 1 cc tube. Because, the formulation avoids the use of strong organic solvents like xylene, cyclohexanone, and toluene, there is greater choice of tube material. Single dose containers make storage and disposal more convenient for animal owners. Multiple dose liquid formulations can be packaged in pho- toresistant containers of more than 1 cc capacity. The high concentration composition also decreases container size requirements for multiple dose containers as well as the container size requirements for single dose containers for larger animals. Again, the smaller container sizes are more conveniently stored and disposed. It has been discovered that a composition including a pyre¬ throid in concentrations greater than 50% and up to 85% can be prepared and that said highly concentrated composition is effective for topical application for control of ectopara- sites such as fleas and ticks, on animals, especially ca¬ nines, while remaining non-toxic and non-irritating to the host. In one aspect of the invention the pyrethroid used is perme- thrin. The composition preferably comprises 65% permethrin in a carrier, preferably the solvent carrier 2-(2-methoxyet- hoxy)ethanol. The composition may include other inert ingredients such as perfumes, skin conditioners or coat sheeners. A preferred composition is in a pourable form so that it can be easily applied to the fur and skin of host animals. The preferred composition is non-irritating to the host skin, coat, and fur and is also not systemically toxic to the host. The present invention is a composition for controlling ectoparasites that can be found on animals and methods for preparing and using the composition. Generally, the compo¬ sition comprises pyrethroid and a carrier. Pyrethroids are a class of chemicals, that have shown effi¬ cacy against ectoparasites. Suitable pyrethroids include permethrin, cypermethrin, cyhalothrin, deltamethrin, flume- thrin and fenvalerate. The most preferred pyrethroid for use in this invention is permethrin. Permethrin has a technical name of 3-(phen-oxyphenyl)-methyl-(IRS)-cis, rans- 3-2,2-dichloroethenyl)-2,2-dimethylcyclopropane carboxylate and a formula of: [Ar denotes a phenyl group] Permethrin has a molecular weight of 391.29 grams/mole and technical permethrin comprises from about 25 to 80% cis and about 20-75% trans isomers by weight. In the insecticidal composition of the invention, technical permethrin is suit¬ able and it preferably has a minimum amount of the trans isomer of about 45% by weight and a minimum amount of cis isomer of about 35% by weight. Any carrier that can deliver a pyrethroid, preferably perme¬ thrin, is a suitable carrier substance to comprise the pyrethroid composition so long as the carrier is also not irritating to the host's skin and not systemically toxic to the host and allows distribution to and absorption by the target parasite. Some suitable liquid carriers include most alcohols, aromatic petroleum products, corn oil, eucalyptus oil, dimethyl glycol, glycol ether, and 2-(2-methoxybutoxy)- ethanol and 2-(2-methoxyethoxy)ethanol. The compound 2-(2- methoxyethoxy)ethanol is the preferred liquid carrier for use in the insecticidal composition of the present inven¬ tion. It is surprising to find that the insecticidal composition of the present invention comprising such a high percentage of the active ingredient, a pyrethroid, is effective against ectoparasites while remaining non-irritating and non-toxic to the host. A composition of the insecticidal composition having such a high concentration of active ingredient also allows for small, easily applied, and yet effective doses. No special expertise is required to apply the treatment so animal owners may do so without the assistance of a veteri¬ narian. Other inert ingredients can be added to the present composi¬ tion and can include up to 15% w/w of the total composition and can include spreading agents, synergists, attractants, repellents, adhesion promoters, surface active agents, stabilizers, skin conditioners, perfumes, coat sheeners and coloring agents. Suitable spreading agents are liquids which distribute themselves particularly readily on the skin. Dipropylene glycol monomethylether is a particularly suitable spreading agent for inclusion within the compositions of the present invention. Isopropyl myristate is within the compositions of the present invention. Isopropyl myristate is another Suitable spreading agents are liquids which distribute themselves particularly readily on the skin. Dipropylene glycol monomethylether is a particularly suitable spreading agent for inclusion within the compositions of the present 5 invention. Isopropyl myristate is within the compositions of the present invention. Isopropyl myristate is another commonly used spreading agent The desirable properties of spreading agents, sometimes referred to as spreading oils, are generally well known to those skilled in the art. 10 Attractants include phermones such as 2,6-dichlorophenol. Repellents include citronellol, diethyl toluimide, dimethyl phthalate, and the like. Of the other inert ingredients that can be utilized with the 5 present invention there are the adhesion promoters. Adhe¬ sion promoters include carboxymethyl-cellulose, methylcellu- lose and other cellulose derivatives and starch derivatives, polyacrylates, alginates gelatin, gum arabic, polyvinylpyr- rolidone, polyvinyl alcohol, copolymers of methyl vinyl 20 ether and aleic anhydride, polyethylene glycols, paraffins, oils, waxes and hydrogenated castor oil, colloidal silicic acid or mixtures of the substances mentioned. The compositions of the present invention do not normally 25 contain surface active agents; however these may be included if desired. Surface-active agents (comprising emulsifiers and wetting agents) include: 1. anionic surface active agents, such as Sodium lauryl sulfate, fatty alcohol ether- sulfates and monoethanolamine salts of mono-/di-alkylpolyg- 3 0 lycol ether orthophosphoric acid esters, 2. cationic surface active agents, such as cetyltrimethyl-ammonium chloride, 3. amphophilic surface-active agents, such as Di- sodium-N-lauryl-amino-diproprionate or lecithin, and 4. non-ionic surface active agents, for example, polyox- 35 yethylated castor oil, polyoxyethylated sorbitane monoleate, sorbitan monostearate, ethyl alcohol, glycerol monostearate, polyoxyethylene stearate and alkylphenol polyglycol ethers. For preventing chemical degradation which occurs in the case of some active compounds, stabilizers may also be used and include, for example, antioxidants, such as tocopherols, butyl-hydroxyanisole, butylhydroxytoluene and carbodiimides, e.g. 2,2-6,6-tetraisopropyldiphenylcarbo-diimide) and scavengers such as epi-chlorhydrin. Coloring agents include conventional dyes which are soluble in the carrier of the present invention, such as Sudan red or Oil Golden Yellow. In order to prepare the insecticidal composition of the present invention, a pyrethroid is heated to 65-80 degrees Centigrade until any crystals present are liquefied. The liquid is then mixed until uniform. A liquid carrier sol¬ vent is placed into a separate unheated vessel. The perme- ■ chrin is then added to the vessel. The permethrin and carrier solvent are then mixed to uniformity. Additives may also be included in the vessel and mixed into the formula¬ tion. The additives comprise traditional pharmaceutical additives like skin conditioners, perfumes, coat sheeners, and spreading agents. In the preferred embodiment of this invention, permethrin is heated to about 65 degrees centigrade. The carrier 2-(2- methoxyethoxy)ethanol is placed in a clean tank and the permethrin added and mixed until uniform. After the perme¬ thrin has been formulated into this simple liquid mixture, the mixture may serve as a starting point for the formula¬ tion of topical preparations in other physical states. For instance, gelling agents may be added to create topical preparations in the form of gels and sols. Gases may be added to create topical preparations that can be delivered as aerosols. Other formulating agents may be added to the liquid mixture to create ointments and pastes. The insecticidal composition of the present invention is suitable for use on mammals, preferably domesticated compan¬ ion animals such as dogs. Because it is so surprisingly non-toxic, it may be used on puppies as well as adult ani¬ mals. It is also useful on a variety of domestic animals except that its use is not recommended for cats. It is also effective against a variety of parasites including ticks, fleas, keds, and mites. 5 The composition according to the present invention is par¬ ticularly useful for horses and other large mammals because the doses required are much smaller as compared to the pyrethroid compositions of 50% or lesser concentrations taught by the prior art. The insecticidal composition of 10 this invention is useful for the control of insect and ascarine ectoparasites such as fleas, ticks, keds, and mites. Its most preferred use is for the control of ticks and fleas on dogs. 15 The composition may be applied to the host animal by any conventional method for the localized application of compo¬ sitions, for example by dropping a small volume of liquid composition on the animal's body. One advantage of the use of a highly concentrated composition is that only a small 20 volume is necessary. While the necessary amount of the composition of the present invention needed to be applied for effective insecticidal activity depends upon the size of the animal and the precise concentration and delivery capa¬ bilities of the particular composition, a 1 ml volume of the 25 preferred liquid composition has been found to be effective on dogs weighing less than 15 kg. A 1-2 milliliter volume of the preferred 65% w/w permethrin delivers 65-130 mg permethrin. On dogs larger than 15 kg, it has been found to be effective to apply 1 ml of 65% permethrin composition 30 between the shoulder blades in conjunction with another 1 ml at the tailhead. The method for applying the preferred embodiment of the invention, its efficacy, as well as the absence of toxicity 35 and irritation, is illustrated, by way of example only, by the following in-vivo experiments: EXPERIMENT 1 Animals Twenty dogs were selected according to health and their ability to maintain parasite infestations and divided into four groups of five dogs each. The condition of each animal was checked daily. On day 0, three groups of five dogs were treated with a dosage of a liquid formulation consisting of 65% w/w perme¬ thrin and 35% w/w 2-(2-methoxyethoxy)ethanol, and the other group of five dogs was left untreated. Treatments were applied to the skin by parting the hair in each treatment location. Treatment locations were between the shoulder blades and at the tailhead. Each treatment location re¬ ceived 1 milliliter of the formulation. Treatment groups are defined in Table 1 entitled Experimental Design. TABLE 1 Experimental Design Group 1: Five dogs of various weights - untreated Group 2: Five dogs less than 33 lbs receiving 1 treatment between the shoulder blades. Group 3: Five dogs less than 33 lbs receiving treatment between the shoulder blades and at the tailhead. Group 4: Five dogs over 33 lbs receiving treatment between the shoulder blades and at the tailhead. Infestations One hundred unfed, adult fleas and 50 unfed, adult brown dog ticks were applied to each dog on the days specified in the following Activity Schedule. At each infestation the unfed, adult parasites were placed along the dorsal midline of each dog from its head to the base of its tail. Parasite Counts Counts were made of the live fleas and ticks remaining on each dog on the days specified in the following Activity Schedule given in Table 1. Tick records indicate the loca- tion, sex, and stage of engorgement of each live, attached tick. The untreated dogs were counted first, and the examiners wore gloves during the examination. The examination table was washed and the examiners changed gloves following the examination of each treated group. Examinations were con¬ ducted according to the activity schedule shown in Table 2. TABLE 2 Activity Schedule ,Day Activity -14 Begin preconditioning dogs - 4 Infest w/ticks ~ 1 Infest w/fleas 0 Count fleas and ticks. Select dogs, weigh Assign to groups, and treat 1 Count fleas 2 Count fleas 3 Count fleas and ticks, remove ticks, reinfest w/ticks 6 Reinfest w/fleas 7 Count fleas and ticks, remove ticks 10 Reinfest w/ticks 13 Reinfest w/fleas 14 Count fleas and ticks, remove ticks 19 Reinfest w/ticks 20 Reinfest w/fleas 21 Count fleas and ticks, remove ticks 24 Reinfest w/ticks 27 Reinfest w/fleas 28 Count fleas and ticks, remove ticks 31 Reinfest w/ticks 34 Reinfest w/fleas 35 Count fleas and ticks ======== ■ ============= ■ = • ======-==== ■ == Evaluation The following parameters were used for tabulating results: (1) Visual counts of fleas (ticks) on host; and (2) Percent control of fleas (ticks) on host = RESULTS: Fleas The three treatments with the preferred composition were performed similarly throughout the study with percent control ranging from 70 to 89 on Day 1, 87 to 100 on Day 2, 92 to 100 on Day 3, 99 to 100 on Day 7, 97 to 100 on Day 14, 99 to 100 on Day 21, 93 to 95 on Day 28 and 63 to 89 on Day 35. Group 3 (dogs weighing less than 33 pounds and treated with 1 cc. between the shoulder blades and 1 cc. at the tailhead) had noticeably higher control figures at Days 1 and 2 than Group 2 (dogs weighing less than 33 pounds and treated with 1 cc. between the shoulder blades only) and Group 4 (dogs weighing more than 33 pounds and treated with 1 cc. between the shoul¬ der blades and 1 cc. at the tailhead) . Group 3 reached 89 and 100 percent control of Days 1 and 2 respectively whereas Group 2 reached 75 and 90 percent control and Group 4 reached 70 and 92 percent control on Days 1 and 2. Also, from Day 3 through Day 28, Group 3 was slightly higher (one to eight percentage points) in percent control than Group 2 and Group 4. A summary of flea counts and percent control of fleas is presented in Table 3. TABLE 3 Flea counts and percent control of fleas; Groups defined in Text, p. 12. TIME TREATMENT Group 1 Group 2 Group 3 Group 4 less than less than greater than 15 kg 15 kg 15 kg None Shld. Shld,. /Tail Shld. /Tail Day -1 Fleas 209 274 270 209 Day 1 Fleas 195 49 22 59 % Control 75 89 70 Day 2 Fleas 184 19 0 24 % Control 90 100 87 Day 3 Fleas 165 12 0 14 % Control 93 100 92 Day 7 Fleas 279 0 0 4 % Control 100 100 99 Day 14 Fleas 254 8 0 2 % Control 97 100 99.2 Day 21 Fleas 312 3 0 3 % Control 99 100 99 Day 28 Fleas 297 19 14 21 % Control 94 95 93 Day 35 Fleas 289 106 64 33 % Control 63 78 89 (a. Shld. denotes that the treatment site was between the shoulder blades.) [b. Shld./Tail denotes that treatments were at two sites, one between the shoulders and the other at the tail head.) Ticks Control of attached ticks on Day 3 was 70 percent in Group 2, 59 percent in Group 3 and 49 percent in Group 4. Groups 2 and 3 were similar in control (96-100 percent control) of post-treatment tick infestation through Day 21. Group 4 stayed at 90 percent control from Day 7 to 14 then increased to 98 percent control on Day 21. By Days 28 and 35 the tick control figures for all three groups were falling slightly to 88-96 percent on Day 28 and 84 to 92 percent on Day 35. Tick counts and percent control are summarized in Table 4. TABLE 4 Total ticks and percent control of Ticks: Groups defined in Text, p. 12. TIME TREATMENT Group 1 Group 2 Group 3 Group 4 less than less than greater than 15 kg 15 kg 15 kg •; None Shld. Shld. /Tail Shld. /Tail Day -1 Ticks 131 99 98 114 Day 3 Ticks 63 19 26 32 % Control 70 59 49 Day 7 Ticks 110 4 0 11 % Control 96 100 90 Day 14 Ticks 119 1 1 12 % Control 99.1 99.1 90 Day 21 Ticks 183 1 2 4 % Control 99.5 99 98 Day 28 Ticks 203 24 9 16 % Control 88 96 92 Day 35 Ticks 193 16 23 30 % Control 92 88 84 (a. Shld. denotes treatment site was between the shoulder blades.) (b. Shld./Tail denotes that treatments were at two sites, one between the shoulders and the other at the tail¬ head.) Adverse Reaction No adverse reactions occurred. An oily residue was evident in the hair surrounding the sites treated with the invented formulation, but no skin irritation, dermatitis, or hair loss occurred. EXPERIMENT II. Permethrin toxicity studies have been completed in numerous species, including rats, mice, rabbits, dogs, cats, cattle, poultry, swine and horses. This study documents the safety of the invention embodiment consisting of 65% permethrin and 35% 2(2-methoxyethoxy) ethanol on dogs. Experimental Design Five dogs were randomly assigned to each treatment group; two dogs served as untreated controls. All dogs were mixed breed, six months to one year of age and 15 to 25 pounds in weight. Complete chemistry profiles were completed on each of 12 dogs prior to initiation of the study. Dogs were examined by a veterinarian and judged to be healthy prior to the treatment phase. Treatment Regime The two treatments consisted of 1 cc or 4cc of 50% permethrin in 2-(2-methoxyethoxy)ethanol. Each dog was individually treated by administering the indicated amount of material (lcc or 4cc) to the shoulder blade area using a lcc eyedropper. Dogs were observed for any signs of adverse reactions, includ¬ ing, but not limited to diarrhea, vomiting, salivation, exces¬ sive lacrimation, muscle fasciculations, hyperactivity, de¬ pression or anorexia. Dogs were noted as being normal if no signs were observable and the dog appeared similar to pre- treatment observations and untreated dogs. Observations were noted immediately at the time of treatment, at two, four, six and eight hours after treatment and daily thereafter for four days. The treatment and observation process was repeated on days 7 through 11 and again on days 14-18, resulting in three treatments and three weeks of observations. Results No adverse reactions were noted in any dog at any time during the course of this study. All dogs exhibited normal behavior. Food and water consumption remained normal throughout the study. Conclusion No adverse reactions were noted after dogs were repeatedly treated with the preferred formulation (permethrin formulated as a ready-to-use spot-on topical applicant) . Additionally, this formulation exhibits a wide margin of safety, with no acute toxicological reactions at 4X the effective dose. This study demonstrates that the most preferred formulation is safe for use on dogs even when applied at several times the recom¬ mended dose.

Claims: CLAIMS 1. A topically applied composition for controlling ectopara¬ sites on non-human domestic mammals comprising a non-toxic, non-irritating quantity, but greater than 50% w/w of a pyre¬ throid, in a carrier. 2. A composition according to claim 1 in which the carrier is a liquid selected from the group comprising alkyl glycol ethers. 3. A composition according to claim 2 in which the liquid solvent is selected from the group consisting of 2-(2- butoxyethoxy) ethanol and 2-(2-methoxyethoxy)etha-nol. 4. A composition according to claim 1 comprising a solution of said pyrethroid dissolved in said carrier. 5. A composition according to claim 1, wherein said pyre¬ throid is selected from the group consisting of permethrin, phenothrin, deltamethrin, cypermethrin, cyhalothrin, flume- thrin, cyfluthrin, cyphenothrin, tralomethrin, tralocythrin and fenvalerate. 6. A topically applied composition for controlling ectopara¬ site infestations on non-human, domestic mammalian hosts comprising a permethrin selected from the group comprising compositions of the formula: Cl 0 =CH—CH- -CH- •CH. -Ar- -Ar Cl CH 3 CH 3 [Ar denotes a phenyl group] and stereo-isomers thereof, in a non-irritating, non-toxic quantity comprising greater than 50% w/w in a carrier. 7. A method of controlling ectoparasite infestation on non- human, domestic, mammalian hosts which comprises applying to a localized region of the skin of said host a composition com¬ prising greater than 50% w/w of a pyrethroid and a carrier. 8. A method according to claim 7 in which a major portion of the formulation is selected from the group consisting of 2-(2- butoxyethoxy)ethanol and 2-(2-methoxyethoxy)ethanol. 9. A method according to claim 7 wherein said host is select¬ ed from the group consisting of dogs and horses. 10. A method according to claim 8 wherein said applying step comprises applying a dose of more than 33.3 mg per kilogram host body weight.

Inventors: GLADNEY JULIE G, SEYMOUR DAVID S, GLADNEY, JULIE, G., SEYMOUR, DAVID, S.
Applicants: COOPERS ANIMAL HEALTH, COOPERS ANIMAL HEALTH, INC.
Application year: 1991
Main classification: A01N25
IPC codes: A01N25, A01N53